PCOS Is Now PMOS: India's Clinical and Patient Guide to the 2026 Rename

PCOS is now called PMOS, short for polyendocrine metabolic ovarian syndrome. A global consensus published in The Lancet in 2026 changed the name because the condition involves several hormone systems and your metabolism as well as your ovaries, and because the old name wrongly suggested ovarian cysts. The condition itself is the same, so your PCOS diagnosis and treatment plan still stand while the new name comes in.

You were never "just hormonal"

If you have spent years being told you have "PCOS, polycystic ovarian syndrome," you may have noticed how little that name explained. Your doctor circled a blurry ultrasound image and mentioned cysts. But what about the relentless fatigue, the insulin spikes after a single roti, the thyroid readings that were never quite right, the weight that refused to budge even on a strict diet? The ovaries were the messenger. The whole system was the problem.

In May 2026, a global clinical consortium confirmed what many women had long suspected: the name was always wrong. The condition has been officially renamed PMOS, Polyendocrine Metabolic Ovarian Syndrome, in a paper published in The Lancet. PCOS has not gone anywhere. It is the same condition, finally with a label that is honest about what it is.

What changed, and why

The Global Name Change Consortium did not rush. The consortium worked with 56 leading academic, clinical and patient organisations, and its global surveys drew responses from 14,360 people with PCOS and health professionals from every world region. The new name won because it is more accurate: it drops the idea of cysts and names the endocrine, metabolic and ovarian sides of the condition together. Worldwide, the paper notes, the condition affects one in eight women.

India was not a bystander. Dr. M. Patil of Dr Patil's Fertility and Endoscopy Clinic in Bengaluru is one of the paper's authors, so Indian clinical experience was part of the process.

So why PMOS? Each word in the new name earns its place:

• Polyendocrine: this is not a single-gland condition. The thyroid axis, adrenal axis, ovarian axis, and pancreatic function are all frequently dysregulated. Treating only the ovaries while ignoring insulin resistance or subclinical hypothyroidism is not complete care.
• Metabolic: insulin signalling, lipid metabolism, adipokine function, and body composition are core features of this syndrome, not secondary consequences.
• Ovarian: the ovaries remain centrally involved. Cycle irregularity, anovulation, and fertility challenges are real. The ovaries are not removed from the picture; they are simply no longer the entire picture.

"Syndrome" stays because PMOS is still understood as a cluster of related but varied presentations rather than a single, uniform disease. The 2023 international PCOS guideline had already widened the picture, listing metabolic risk factors, cardiovascular disease, sleep apnoea and psychological features among the condition's broader features.

If you want the whole picture in one place, including how we approach PMOS through Ayurveda, read our full explainer on understanding PMOS.

What PMOS actually means for the Indian body

This rename matters a great deal in India. A nationwide study by the Indian Council of Medical Research (ICMR), run across five zones of the country, enrolled 8,993 women aged 18 to 40. It found a national prevalence of 19.6% by the Rotterdam criteria, close to one in five women. In the ICMR study, the most common pattern was phenotype C (40.8%): hyperandrogenism combined with polycystic ovarian morphology, often without classic ovulatory dysfunction as the presenting complaint.

The metabolic co-morbidity profile in Indian PMOS is striking. Among the 1,224 women with PCOS in the ICMR study, 43.2% had obesity, but 91.9% had abnormal blood lipids (dyslipidaemia), 32.9% had non-alcoholic fatty liver disease and 24.9% had metabolic syndrome. So a normal weight does not rule out metabolic trouble, which is why insulin resistance deserves a look even in slim women. The body weight is not the diagnosis; the metabolic and endocrine signalling is.

This is what "polyendocrine" captures and "polycystic" never could: when a patient presents with thyroid antibodies, borderline fasting insulin, irregular periods, and acanthosis nigricans despite a "normal" BMI, the clinical picture is no longer mysterious. That is what PMOS looks like. If thyroid problems are part of your picture, our guide to PMOS and the thyroid explains the link.

What actually changes for you as an Indian patient

In practice, less changes than you might expect in the short term, and more over the next decade.

Your records and insurance are unaffected. The consortium has planned a transition period, with education and alignment with health systems and disease classification codes. Until then, your hospital discharge summary, your health insurance documents, and your diagnostic paperwork will likely still say "PCOS" or use PCOS-era ICD codes. That is not an error, just a system that is still catching up.

Your doctor may not have switched yet. Many clinicians in India will keep using "PCOS" in clinical notes for some time, particularly in tier-2 and tier-3 cities where guideline adoption takes longer. If your doctor has not heard of PMOS, that does not mean your diagnosis is wrong or that the naming change is disputed. It simply means the guideline refresh is still rolling out.

Your treatment plan does not automatically change. The rename did not introduce new drugs, new diagnostic criteria, or new treatment protocols overnight. If you are currently managing PMOS with metformin, clomiphene, lifestyle changes, or any other approach, do not stop or restart anything based on the name change alone. The science behind your current treatment is not invalidated.

Search terms still work both ways. "PCOS" is not an illegal search term. It will keep returning relevant results for years. If you are researching symptoms, clinical trials, or nutrition protocols, searching for either PCOS or PMOS will surface the same underlying evidence base. Both names point to the same condition.

What has changed is the clinical conversation you are entitled to have. The rename gives you language to ask: "Are we looking at my full endocrine picture? Has anyone checked my blood sugar? My thyroid peroxidase antibodies? My lipid panel?" The name PMOS opens that door, and this guide to what doctors often miss can help you prepare.

The Qura perspective: why this validates whole-system care

At Qura, we find this rename meaningful because it matches the clinical framework we have always worked within.

Ayurvedic and integrative frameworks have never treated this condition as ovary-only. The concept of Aartava Kshaya in classical Ayurveda already recognised the link between Medo dhatu (fat tissue), Medavaha srotas (metabolic channels), and menstrual irregularity. The understanding that metabolic function and reproductive function are inseparable is not new in Indian medicine. Ayurveda has always worked from that idea.

The PMOS rename says the same thing in a language that modern clinical medicine can hear.

Three things to do this week

1. Ask for a full metabolic check at your next appointment. Blood sugar (fasting glucose or HbA1c), a full lipid panel, and thyroid function (TSH, and ideally TPO antibodies) give a more complete PMOS picture than a pelvic ultrasound alone.
2. Update your health records vocabulary. When describing your condition to new doctors, you can say "I have PMOS (formerly PCOS)", most clinicians will recognise both terms, and the dual reference helps ensure continuity of care.
3. Share this with someone who needs it. PMOS is common in India, so someone in your family or friend circle is probably managing it too. The rename may help them ask better questions at their next appointment.

When to see a doctor

See a gynaecologist, or an endocrinologist if your doctor refers you, if:

• your periods stop for several months, or come so far apart that you cannot predict them
• bleeding is very heavy or lasts much longer than usual
• you have been trying to conceive without success
• dark, velvety patches appear on your neck or underarms, or facial hair and acne get worse quickly
• you feel unusually thirsty, pass urine often or lose weight without trying, which can be signs of high blood sugar

If you are pregnant, breastfeeding or already taking medication, check with your doctor before trying any herb or supplement for PMOS, and never stop a prescribed medicine on your own.

Get a plan built for you

An article can explain what usually happens and why. It can't read your reports. To know whether your symptoms come from PCOS, your thyroid, your weight, stress or something else, a doctor has to look at your whole history.

A Qura consultation is a video call with a BAMS Ayurvedic doctor. She goes through your reports with you and builds a 90-day plan that covers your diet, Ayurvedic medicine and regular follow-ups. We won't tell you PCOS will simply go away, because no honest doctor can promise that. What we can do is find what is actually driving your symptoms and work on that.

See how the 3-month PMOS (PCOS) program works, or book your consultation.

This article is for general information and can't replace advice from your own doctor. Please don't start or stop any medicine, herb or supplement without talking to a qualified doctor first, especially if you are pregnant, breastfeeding or already on medication.